优化头颈癌放疗中反应性 versus 预防性胃造瘘管置入的选择
本研究基于单中心2018-2021年头颈癌放疗患者数据,比较预防性胃造瘘(pGT)与反应性策略(rGT)患者的特征与体重结局。多因素分析识别了rGT组中需置管或体重下降>10%的预测因素,并建立预测模型,旨在优化pGT与rGT的个体化选择,但模型需外部验证。
要点
- pGT组更常见晚期肿瘤、低基线功能经口摄入量表、双侧颈部放疗、同步化疗及更高咽部平均剂量。
- pGT组与rGT组体重下降结局相似。
- 多因素分析识别了rGT组中需置管或体重下降>10%的显著预测因素,并建立预测模型。
核心结论
- 在采用rGT策略的头颈放疗患者中,识别了治疗期间需胃造瘘置管或过度体重下降的预测因素,并建立了预测模型。
- 识别高风险的显著体重下降和/或需置管患者,可能优化rGT与pGT的个体化选择。
- 该模型预测最终接受rGT高风险患者的能力需外部验证。
研究设计与样本
- 单中心回顾性分析2018至2021年头颈癌放疗患者数据。
- 共202例符合纳入标准:pGT组86例,rGT组116例。
- rGT组进一步分为rGT-conditional(置管或放疗期间体重下降>10%)和rGT-appropriate(未置管且体重下降<10%)。
- 采用混合线性模型评估放疗后12个月内的体重下降。
- 在rGT组内采用多因素logistic回归建立预测rGT-conditional的模型。
主要发现
- pGT组更可能有晚期肿瘤分期、较低基线功能经口摄入量表、双侧颈部放疗、同步化疗及更高咽部平均放疗剂量。
- pGT组与rGT组体重下降结局相似。
- 多因素分析识别了rGT-conditional的多个显著预测因素。
关键数值与推荐
- rGT-conditional定义为置管或放疗期间体重下降>10%。
- rGT-appropriate定义为未置管且放疗期间体重下降<10%。
临床怎么用
- 在头颈癌放疗前采用rGT策略时,可参考本模型识别需置管或显著体重下降的高风险患者。
- 根据预测风险个体化选择pGT或rGT,以优化营养支持路径。
局限性
- 单中心回顾性研究,样本量202例。
- 预测模型需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To develop a predictive assessment for determining patients at high risk of reactive gastrostomy tube (GT) placement during radiation therapy (RT) for head and neck cancer. METHODS AND MATERIALS: Data of patients with head and neck cancer treated with RT from 2018 to 2021 at a single institution were analyzed. Baseline patient characteristics were obtained and used to compare patients receiving prophylactic GT (pGT) with those who did not receive a pGT (reactive, or rGT group). Patients in the rGT group were further categorized as rGT-conditional (had GT placed or experienced > 10% weight loss during RT) or rGT-appropriate (no GT placed and < 10% weight loss during RT). Clinical, disease, and dosimetric factors were abstracted from the medical record, including dose to dysphagia/aspiration-related structures. A mixed linear model was used to assess weight loss through 12 months post-RT. Within the reactive group, multivariable logistic regression was used to develop a model predicting rGT-conditional cases who experienced rGT placement or weight loss > 10% during RT. RESULTS: A total of 202 patients met the inclusion criteria: 86 in the pGT group and 116 in the rGT group. Patients in the pGT group were more likely to have advanced tumor stage, lower baseline functional oral intake scale, bilateral neck RT, concurrent chemotherapy, and higher mean pharynx dose of RT. Weight loss outcomes were similar between groups. Multivariable analysis identified several significant predictors of rGT-conditional cases. CONCLUSIONS: Among patients planned for head and neck RT using an rGT paradigm, we identified predictors of GT placement or excessive weight loss on-treatment and developed a predictive model of GT placement in this group. Identifying patients at high risk of substantial weight loss and/or GT placement during RT may optimize personalization of rGT versus pGT. External validation of this model's ability to predict patients at high risk of ultimately receiving rGT is warranted.
引用
- Gallardo NA, Razavian NB, Lanier CM, et al. Optimizing Selection of Reactive versus Prophylactic Gastrostomy Tube Placement in Patients Treated with Radiation Therapy for Head and Neck Cancer. Adv Radiat Oncol. 2025. PMID: 41550206. doi:10.1016/j.adro.2025.101930
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。